What’s happening in the life sciences industry that may have significant tax implications for your company’s decision-making? In this podcast, Tony Castellanos, Tax Industry Leader for KPMG LLP (KPMG), and Christine Kachinsky, KPMG Life Sciences Tax Industry Leader, examine three current trends in the industry and how they translate into tax issues that CFOs at life sciences companies may want to discuss with their head of tax, including:
- New investments in research and development
- Digital transformation throughout the enterprise
- Active M&A environment.
Our broad range of tax planning and compliance services can help you manage tax risks and opportunities.
What the New R&D Tax Rule Means for Life Sciences Companies
The cross-over effects of tax policy and accounting and financial reporting are extensive.